GFC Life Science지에프씨생명과학
388610 · KOSDAQ · ₩388610 · 지에프씨생명과학
₩4,445▼ ₩35 (0.78%)End-of-day · Oct 29, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | |
|---|---|---|
| Revenue | ₩18B | ₩17B |
| Cost of sales | ₩9.2B | ₩8.9B |
| Gross profit | ₩8.5B | ₩7.9B |
| Operating income | ₩386M | ₩1.7B |
| Net income | ₩555M | −₩5.9B |
| Net income to shareholders | ₩555M | −₩5.9B |
Balance sheet
| 2025 | 2024 | |
|---|---|---|
| Total assets | ₩34B | ₩20B |
| Current assets | ₩11B | ₩3.9B |
| Cash and equivalents | ₩7.5B | ₩1.5B |
| Total liabilities | ₩10B | ₩9.2B |
| Current liabilities | ₩2B | ₩6.9B |
| Borrowings | ₩7B | ₩6.4B |
| Total equity | ₩24B | ₩11B |
| Shareholders' equity | ₩24B | ₩11B |
Cash flow
| 2025 | 2024 | |
|---|---|---|
| Cash from operations | ₩1.4B | ₩3B |
| Capital spending | ₩7.7B | ₩3B |
| Free cash flow | −₩6.3B | −₩36M |
Consolidated where available. Amounts in won.
Also known as: GFC Life Science / 지에프씨생명과학 / 388610 / KRX:388610
Source: KRX statistical information